BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biologics

Peijia Medical Completes Enrollment for TaurusTrio™ Aortic Regurgitation Trial

The multi-center trial utilized the TaurusTrioTM TAVR system to treat pure AR in 116 patients across 13 hospitals within China and is design...

January 30, 2024 | News

Ractigen Therapeutics Partners with Utrecht Medical Center for saRNA Innovation in Neurodevelopmental Disorders

Professor Bobby Koeleman, Group Leader at the Department of Genetics within the Center for Molecular Medicine at Utrecht University, will le...

January 30, 2024 | News

Travere Therapeutics Licenses Sparsentan to Renalys Pharma for Japan, South Korea, Taiwan, and Southeast Asia

Travere Therapeutics,announced that it has entered into an exclusive licensing agreement with Renalys Pharma, Inc., to bring sparsentan, a dual endothelin ...

January 29, 2024 | News

Bristol Myers Squibb's Abecma CAR T Therapy Earns Favorable CHMP Opinion for Earlier Lines in Multiple Myeloma

Recommendation for approval based on Phase 3 KarMMa-3 study in which Abecma demonstrated superiority over standard regimens, significantly improv...

January 26, 2024 | News

Merck's Strategic Agreement with Heavy Water Board Boosts Local Manufacturing for Deuterated Compounds in India

In a recent interview with BioPharma APAC, Jean Charles Wirth, Executive Vice President of Science & Laboratory Solutions at Merck, sheds light...

January 26, 2024 | Interview

Ceva Santé Animale Acquires Scout Bio for Innovative Pet Therapeutics

The move represents a significant leap in innovation for Ceva, unlocking access to key advancements including a pipeline of monoclonal antibodies and ...

January 26, 2024 | News

AbbVie Invests $223M to Expand Biologics Manufacturing in Singapore

US$223 million expansion will add biologics capacity to AbbVie manufacturing network Singapore manufacturing site to grow to more than 500 emp...

January 26, 2024 | News

Onward Therapeutics Initiates Phase 1 Trial for Bispecific Antibody OT-A201 Targeting Dual Immune Checkpoints

The study aims to evaluate the safety, tolerability, pharmacokinetics, immunogenicity, and preliminary anti-tumoral activity of OT-A201. The study is a Eur...

January 25, 2024 | News

Merck and Mycenax Biotech Forge Partnership for Bioprocessing Innovation

Merck announces a non-binding MoU with Mycenax Biotech to optimize bioprocessing production of life-changing biological therapies Integrates company&rsq...

January 24, 2024 | News

WuXi XDC and Celltrion Collaborate on Comprehensive Antibody-Drug Conjugate (ADC) Services

Under the collaboration, Celltrion will delegate WuXi XDC as primary service provider on each of the integrated projects, from process development to GMP m...

January 24, 2024 | News

Thermo Fisher Launches Next-Gen Invitrogen TaqMan Cells-to-CT Express Kit to Advance Lab Sustainability

RT-qPCR is commonly performed to support gene expression analysis, which compares the expression of genes between two or more samples and can help ...

January 23, 2024 | News

Revolutionizing Genomic Research: Thermo Fisher's Axiom™ PangenomiX Array's Breakthroughs in Disease and Pharmacogenomic Studies

In an insightful interaction with BioPharma APAC, Joanne Tsarouha, Sr. Product Manager of Microarray Technology at Thermo Fisher Scientific, delves into th...

January 24, 2024 | Expert Insight

First Myeloma Patient Treated with CAR-T Successfully Released

The foreign patient was first diagnosed with multiple myeloma in 2008. Despite multiple treatments including chemotherapy, immunotherapy, target treatment,...

January 23, 2024 | News

LOTTE BIOLOGICS and NJ Bio, Inc. Forge Strategic Partnership to Revolutionize ADC Services

This partnership leverages LOTTE BIOLOGICS' extensive proficiency in antibody manufacturing and NJ Bio's specialized skills in ADC process development, as ...

January 22, 2024 | News

Stay Connected